Connectyx Technologies Holdings Group's CEO Gives Shareholders a Summary of Events...

* Reuters is not responsible for the content in this press release.

Tue Jun 30, 2009 8:30am EDT

Connectyx Technologies Holdings Group's CEO Gives Shareholders a Summary of
Events for First Half of 2009 and Announces Teleconference Call on July 9th to
Discuss Future Strategy

PALM CITY, Fla., June 30 /PRNewswire-FirstCall/ -- Connectyx (Pink Sheets:
CTYX) - Connectyx Technologies Holdings Group, Inc. is pleased to announce
that Connectyx's CEO, Ronn Schuman, has issued an open letter to shareholders
available for viewing on the Company's Web site at www.connectyx.com.  The
letter addresses many of the events that have taken place during the first six
months of this year, including the addition of several prominent individuals
to the management, sales and marketing teams, and the Company's strategy for
revenue generation for the next six months of 2009.

Mr. Schuman discusses new sales opportunities and strategic partnerships that
have been established over the last six months, as well as initiatives to
increase the Company's market share through numerous channels of distribution.

Ronn Schuman, Connectyx President and CEO, said,  "We believe this shareholder
letter provides a substantive overview of our Company's achievements during
the past six months, including our many initiatives to grow revenues through
marketing and sales of our lead product MedFlash, both nationally and
internationally.  We anticipate that these accomplishments, and our plans for
the rest of the year, will enable us to prepare a Form 10 to file with the SEC
to become a fully reporting company and ultimately obtain listing on the OTC
Bulletin Board within the next 6 months.  I urge all our shareholders and
other interested parties to go to our Web site and find, under Investor
Relations, a link to my Letter to Investors. 

Connectyx recently announced that - on Thursday, July 9, 2009 at 4:15 PM EDT -
management will present a Nationwide Teleconference hosted and moderated by
Marc Jablon, CEO of Big Apple Consulting USA, to discuss recent business
developments and the Company's plans for the remainder of 2009. Space is
limited, so please call (407)389-5900 to reserve your spot for the Connectyx
Nationwide Teleconference.  If you would like to suggest a question for the
Nationwide Teleconference, please email your question to:
questions@connectyx.com. 

About Connectyx Technologies Holdings Group, Inc.

Connectyx Technologies provides products in the healthcare market, which
includes its Personal Health Record, MedFlash. The MedFlash product is an easy
to use Personal Health and Lifestyle Record & Portal that is USB flash drive
enabled. MedFlash contains an emergency flash drive with a Web portal and 24/7
emergency call center access, which contains the owner's complete medical and
key related information. Stored information on the MedFlash can be accessed on
any computer, securely with complete privacy for the members. For more
information, please visit www.connectyx.com and www.medflash.com

Safe Harbor Act: This release includes forward-looking statements made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995 that involves risks and uncertainties including, but not
limited to, the impact of competitive products, the ability to meet customer
demand, the ability to manage growth, acquisitions of technology, equipment,
or human resources, the effect of economic business conditions, and the
ability to attract and retain skilled personnel. The Company is not obligated
to revise or update any forward-looking statements in order to reflect events
or circumstances that may arise after the date of this release.

SOURCE  Connectyx Technologies Holdings Group, Inc.

Public Relations: Big Apple Consulting USA, +1-407-389-5900; or Investor
Relations: Consulting for Strategic Growth, Stanley Wunderlich, CEO,
+1-800-625-2236, Fax: +1646-514-1177, info@cfsg1.com, http://www.cfsg1.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.